Zobrazeno 1 - 10 of 57 pro vyhledávání: '"Jacob A. Sloane"'
1
Akademický článek
Blunted Post-COVID-19 Humoral Immunity in Patients With CNS Demyelinating Disorders on Anti-CD20 Treatments
Autor: Kelli M. Money, Ursela Baber, Emma Saart, Soleil Samaan, Jacob A. Sloane
Publikováno v: Frontiers in Neurology, Vol 13 (2022)
With unclear characteristics of post-infection and post-vaccination immunity, the multiple sclerosis community lacks evidence to guide patients on their continued coronavirus disease 2019 (COVID-19) infection risk. As disease modifying treatments all
Externí odkaz: https://doaj.org/article/0e39d71420b3452ba6a20ad64049c928
Zobrazit plný text záznamu
2
Akademický článek
Quantitative 7-Tesla Imaging of Cortical Myelin Changes in Early Multiple Sclerosis
Autor: Valeria Barletta, Elena Herranz, Constantina A. Treaba, Ambica Mehndiratta, Russell Ouellette, Gabriel Mangeat, Tobias Granberg, Jacob A. Sloane, Eric C. Klawiter, Julien Cohen-Adad, Caterina Mainero
Publikováno v: Frontiers in Neurology, Vol 12 (2021)
Cortical demyelination occurs early in multiple sclerosis (MS) and relates to disease outcome. The brain cortex has endogenous propensity for remyelination as proven from histopathology study. In this study, we aimed at characterizing cortical micros
Externí odkaz: https://doaj.org/article/d7d0d7792d544a97b689a14865ae9d86
Zobrazit plný text záznamu
3
Akademický článek
The association between intra- and juxta-cortical pathology and cognitive impairment in multiple sclerosis by quantitative T2* mapping at 7 T MRI
Autor: Céline Louapre, MD, PhD, Sindhuja T. Govindarajan, MS, Costanza Giannì, MD, Nancy Madigan, PhD, A. Scott Nielsen, MD, MMSc, Jacob A. Sloane, MD, PhD, Revere P. Kinkel, MD, Caterina Mainero, MD, PhD
Publikováno v: NeuroImage: Clinical, Vol 12, Iss C, Pp 879-886 (2016)
Using quantitative T2* at 7 Tesla (T) magnetic resonance imaging, we investigated whether impairment in selective cognitive functions in multiple sclerosis (MS) can be explained by pathology in specific areas and/or layers of the cortex. Thirty-one M
Externí odkaz: https://doaj.org/article/346b48c44f764c2798ff3a0c6b511e11
Zobrazit plný text záznamu
5
CLICK-MS and MASTER-2 Phase IV trial design: cladribine tablets in suboptimally controlled relapsing multiple sclerosis
Autor: Ann D Bass, Joshua Katz, Edward Fox, Derrick Robertson, Danielle E. Harlow, Jacob A. Sloane, Brooke Hayward, Augusto Miravalle, Lori A Lebson
Publikováno v: Neurodegenerative Disease Management. 11:99-111
Cladribine tablets 10 mg (3.5 mg/kg cumulative dose over 2 years) are approved for the treatment of relapsing forms of multiple sclerosis (MS), including relapsing-remitting MS and active secondary progressive MS. However, real-world data on cladribi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d920c53ff76149a3f750fa9e1c954ad1
https://doi.org/10.2217/nmt-2020-0059
Zobrazit plný text záznamu
6
The relevance of multiple sclerosis cortical lesions on cortical thinning and their clinical impact as assessed by 7.0-T MRI
Autor: Ambica Mehndiratta, Jacob A. Sloane, Revere P. Kinkel, Elena Herranz, Eric C. Klawiter, Constantina A. Treaba, Valeria Barletta, Russell Ouellette, Caterina Mainero
Publikováno v: Journal of Neurology. 268:2473-2481
This study aimed to investigate at 7.0-T MRI a) the role of multiple sclerosis (MS) cortical lesions in cortical tissue loss b) their relation to neurological disability. In 76 relapsing remitting and 26 secondary progressive MS patients (N = 102) an
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fdf4cfd367d6d13755707c14360549a8
https://doi.org/10.1007/s00415-021-10400-4
Zobrazit plný text záznamu
7
COVID-19 in teriflunomide-treated patients with multiple sclerosis
Autor: Shahamat Tauhid, Howard L. Weiner, Idanis Berriosmorales, Tamara H.W. Schwartz, Mark S. Freedman, Carolina Ionete, Rohit Bakshi, Biljana D. Beretich, Jacob A. Sloane, Ann Cabot, Paolo Preziosa, Amir-Hadi Maghzi, James Stankiewicz, Massimo Filippi, Maria K. Houtchens
Publikováno v: Journal of Neurology
The outbreak of a severe acute respiratory syndrome caused by a novel coronavirus (COVID-19), has raised health concerns for patients with multiple sclerosis (MS) who are commonly on long-term immunotherapies. Managing MS during the pandemic remains
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4d3402678364eaba398db257e6f5165
https://doi.org/10.1007/s00415-020-09944-8
Zobrazit plný text záznamu
8
Blunted Post-COVID-19 Humoral Immunity in Patients With CNS Demyelinating Disorders on Anti-CD20 Treatments
Autor: Kelli M. Money, Ursela Baber, Emma Saart, Soleil Samaan, Jacob A. Sloane
Publikováno v: Frontiers in neurology. 13
With unclear characteristics of post-infection and post-vaccination immunity, the multiple sclerosis community lacks evidence to guide patients on their continued coronavirus disease 2019 (COVID-19) infection risk. As disease modifying treatments all
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::789d3ee1cdcb8d06d1878c687e653b9f
https://pubmed.ncbi.nlm.nih.gov/35280260
Zobrazit plný text záznamu
9
Profiles of cortical inflammation in multiple sclerosis by 11C-PBR28 MR-PET and 7 Tesla imaging
Autor: Julien Cohen-Adad, Céline Louapre, Constantina A. Treaba, Gabriel Mangeat, Elena Herranz, Russell Ouellette, Caterina Mainero, Marco L. Loggia, Jacob A. Sloane, Eric C. Klawiter, Sindhuja T. Govindarajan
Publikováno v: Multiple Sclerosis Journal. 26:1497-1509
Background: Neuroinflammation with microglia activation is thought to be closely related to cortical multiple sclerosis (MS) lesion pathogenesis. Objective: Using 11C-PBR28 and 7 Tesla (7T) imaging, we assessed in 9 relapsing–remitting multiple scl
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8ef1ed3b061a0196e903fc472bc0bcbc
https://doi.org/10.1177/1352458519867320
Zobrazit plný text záznamu
10
Real-World Characterization of Dimethyl Fumarate-Related Gastrointestinal Events in Multiple Sclerosis: Management Strategies to Improve Persistence on Treatment and Patient Outcomes
Autor: Andrew Chan, Irene Koulinska, J. Theodore Phillips, Fang Fang, Jinny Min, Enrique Alvarez, Anneke van der Walt, Jacob A. Sloane, Catherine Miller, Stanley Cohan
Publikováno v: Neurology and Therapy, Vol 8, Iss 1, Pp 109-119 (2019)
Neurology and Therapy
Min, Jinny; Cohan, Stanley; Alvarez, Enrique; Sloane, Jacob; Phillips, J Theodore; van der Walt, Anneke; Koulinska, Irene; Fang, Fang; Miller, Catherine; Chan, Andrew (2019). Real-World Characterization of Dimethyl Fumarate-Related Gastrointestinal Events in Multiple Sclerosis: Management Strategies to Improve Persistence on Treatment and Patient Outcomes. Neurology and therapy, 8(1), pp. 109-119. Springer 10.1007/s40120-019-0127-2
Introduction Delayed-release dimethyl fumarate (DMF) is an effective treatment for multiple sclerosis (MS). Some patients experience gastrointestinal (GI) adverse events (AEs) that may lead to premature DMF discontinuation. This study characterized t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ea86001f88a35562037e1738fff3ee5
https://doi.org/10.1007/s40120-019-0127-2
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje